Pneumococcal Conjugate Vaccine (PCV-13) and Experimental Human Pneumococcal Carriage Study (EHPC) Study

Trial Profile

Pneumococcal Conjugate Vaccine (PCV-13) and Experimental Human Pneumococcal Carriage Study (EHPC) Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Hepatitis A vaccine inactivated
  • Indications Pneumococcal infections
  • Focus Therapeutic Use
  • Acronyms PCV and EHPC
  • Most Recent Events

    • 24 Jun 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 09 May 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 04 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top